Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

Lancet Oncology

Volumn 8, Issue 10, 2007, Pages 881-888

  Krag, David N ^a   Anderson, Stewart J ^b   Julian, Thomas B ^c   Brown, Ann M ^b   Harlow, Seth P ^a   Ashikaga, Takamaru ^a   Weaver, Donald L ^a   Miller, Barbara J ^c   Jalovec, Lynne M ^d   Frazier, Thomas G ^e   Noyes, R Dirk ^f   Robidoux, André ^g   Scarth, Hugh MC ^h   Mammolito, Denise M ^d   McCready, David R ⁱ   Mamounas, Eleftherios P ^j   Costantino, Joseph P ^b   Wolmark, Norman ^c  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e BRYN MAWR HOSPITAL   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^h SAINT JOHN REGIONAL HOSPITAL   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j Aultman Health Foundation   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DYE;

ADULT; ALLERGY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CONTROL; CANCER LOCALIZATION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOPERATIVE PERIOD; INVASIVE CARCINOMA; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; OUTCOMES RESEARCH; PALPATION; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE;

EID: 34748832847     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70278-4     Document Type: Article

References (31)

1. Braithwaite L. The flow of lymph from the ileocaecal angle, and its possible bearing on the cause of duodenal and gastric ulcer. Br J Surg 11 (1923) 7-26
2. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
3. Morton D., Wen D., Wong J., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
4. Alex J., and Krag D. Gamma-probe guided localization of lymph nodes. Surg Oncol 2 (1993) 137-143
5. Giuliano A., Kirgan D., Guenther J., and Morton D. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-398
6. White S., and Freedman L. Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer 37 (1978) 849-857
7. Harlow S., Krag D., Julian T., et al. Prerandomization surgical training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 241 (2005) 48-54
8. Snedecor G., and Cochran W. Statistical methods (1980), Iowa State University Press, Ames, IA
9. 2 test. Suppl J R Stat Soc 1 (1934) 217-235
10. Mantel N., and Greenhouse S. What is the continuity correction?. Am Stat 22 (1968) 27-30
11. Agresti A., Wackerly D., and Boyett J. Exact conditional tests for cross-classifications: approximation of attained significance levels. Psychometrica 44 (1979) 75-83
12. Borgstein P., Pijpers R., Comans E., van Diest P., Boom R., and Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186 (1998) 275-283
13. Layeeque R., Henry-Tillman R., Korourian S., Kass R., and Klimberg V. Subareolar sentinel node biopsy for multiple breast cancers. Am J Surg 186 (2003) 730-735
14. Kern K. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. J Am Coll Surg 195 (2002) 467-475
15. Nieweg O., Estourgie S., van Rijk M., and Kroon B. Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients. J Surg Oncol 87 (2004) 153-156
16. Estourgie S., Nieweg O., Olmos R., Rutgers E., and Kroon B. Lymphatic drainage patterns from the breast. Ann Surg 239 (2004) 232-237
17. Krynyckyi B., Chun H., Kim H., Eskandar Y., Kim C., and Machac J. Factors affecting visualization rates of internal mammary sentinel nodes during lymphoscintigraphy. J Nucl Med 44 (2003) 1387-1393
18. Morrow M., and Foster Jr. R. Staging of breast cancer: a new rationale for internal mammary node biopsy. Arch Surg 116 (1981) 748-751
19. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 339 (1998) 941-946
20. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553
21. Kim T., Giuliano A., and Lyman G. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106 (2006) 4-16
22. Martin II R., Chagpar A., Scoggins C., et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 241 (2005) 1005-1012
23. Martin R., Derossis A., Fey J., et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 130 (2001) 432-438
24. Masannat Y., Shenoy H., Speirs V., Hanby A., and Horgan K. Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery. Eur J Surg Oncol 32 (2006) 381-384
25. Grube B., and Giuliano A. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 20 (2001) 230-237
26. Galimberti V. International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol 24 (2006) 210-211
27. Wells S. ACOSOG Z0011 Suspension of Registration. https://www.acosog.org/announcements/announcement_display.jsp?id=c0875d5e-062a-4901-ba65-926a7637c451 (accessed Aug 20, 2007).
28. Rutgers E., Meijnen P., and Bonnefoi H. Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group. Breast Cancer Res 6 (2004) 165-169
29. Mansel R., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 (2006) 599-609
30. Smith M., Gill P., Wetzig N., Sourjina T., Simes R., and Stockler M. Bs06 patient-rated outcome measures were more sensitive than clinician-rated measures at distinguishing the effects of sentinel node biopsy and axillary clearance in the snac trial. ANZ J Surg 77 Suppl 1 (2007) A2
31. Purushotham A., Upponi S., Klevesath M., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 (2005) 4312-4321